Journey Clinical
Transforming Mental Health with Psychedelic-Assisted Psychotherapy
New York, United States · Founded 2021 · $11.5M raised
- Headquarters
- New York, New York
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B2C
- Website
- journeyclinical.com
- Total Funding
- $11.5M
- Last Round
- $8.5M Series AJan 2023
- Rounds
- 2
About
Journey Clinical partners with licensed mental health professionals to safely expand access to Psychedelic-Assisted Psychotherapy, starting with Ketamine-Assisted Psychotherapy. The platform provides therapists with infrastructure, training, and a dedicated in-house medical team that handles patient eligibility, prescriptions, and outcome monitoring. 87% of KAP patients report improvement in depression and anxiety clinical scores.
Summary
Journey Clinical is a Biotech company based in New York, United States, founded in 2021. It has raised $11.5M in total across 2 rounds, most recently a $8.5M Series A round in Jan 2023. Investors include Fifty Years, Union Square Ventures and AlleyCorp.
Tech & App Stack
9 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jan 2023
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company

Specialty pharmaceutical company

